Purchase Order 36C26326P0022
- Not listed
- Edwards Lifesciences LLC, a subsidiary of Edwards Lifesciences Corporation and a global leader in cardiovascular medical devices, was awarded a firm fixed-price purchase order by Veterans Integrated Service Network 23 for a TAVR (transcatheter aortic valve replacement) kit prosthetics delivery on October 24, 2025. The contract, valued at $34,000, is not subject to any set-aside designation and is scheduled for completion by October 28, 2025. The award supports the Department of Veterans Affairs'...
- Edwards Lifesciences LLC, a subsidiary of Edwards Lifesciences Corporation and recognized leader in cardiovascular medical devices, has been awarded a $34,000 firm fixed-price purchase order by Veterans Integrated Service Network 23 for TAVR (transcatheter aortic valve replacement) products. The contract, which was not set aside for any business category, is scheduled for completion by November 17, 2025, with performance occurring in Minneapolis, Minnesota. As the sole manufacturer of the...
- Edwards Lifesciences LLC, a subsidiary of Edwards Lifesciences Corporation and a global leader in cardiovascular medical devices, was awarded a $34,000 firm fixed-price purchase order by the Department of Veterans Affairs' Veterans Integrated Service Network 23 on October 17, 2025. The contract, designated as TAVR (Transcatheter Aortic Valve Replacement), will be performed in Minneapolis, Minnesota and is scheduled for completion by October 20, 2025. This award does not utilize a set-aside...
- Edwards Lifesciences LLC, a subsidiary of Edwards Lifesciences Corporation and a recognized leader in cardiovascular medical device innovation, was awarded a $34,000 firm fixed-price purchase order by Veterans Integrated Service Network 23 on November 7, 2025. The contract, designated as a TAVR (Transcatheter Aortic Valve Replacement) procurement, will be performed in Minneapolis, Minnesota with an ultimate completion date of November 10, 2025. This award carries no set-aside designation and...
- Edwards Lifesciences LLC, a subsidiary of Edwards Lifesciences Corporation and a global leader in cardiovascular medical devices, was awarded a firm fixed-price purchase order on December 8, 2025, by Veterans Integrated Service Network (VISN) 23 for TAVR (transcatheter aortic valve replacement) equipment and related products. The contract, with a ceiling value of $34,000, has an ultimate completion date of December 10, 2025, and will be performed in Minneapolis, Minnesota. No set-aside...
- Edwards Lifesciences LLC, a subsidiary of Edwards Lifesciences Corporation and a leading provider of advanced cardiovascular medical devices, has been awarded a $34,000 firm fixed-price purchase order by Veterans Integrated Service Network (VISN) 23 for specialized transcatheter aortic valve replacement (TAVR) products. The contract, awarded on June 9, 2025, with a completion date of June 11, 2025, is for delivery to Minneapolis, Minnesota. No set-aside designation was applied to this award, and...
- Edwards Lifesciences LLC, a subsidiary of Edwards Lifesciences Corporation and self-certified small disadvantaged business, has been awarded a firm fixed-price purchase order valued at $34,000 by Veterans Integrated Service Network (VISN) 23 for transcatheter aortic valve replacement (TAVR) medical devices. The contract was awarded on November 10, 2025, with an ultimate completion date of November 12, 2025, and will be performed in Minneapolis, Minnesota. This award represents a direct...
- Edwards Lifesciences LLC, a subsidiary of Edwards Lifesciences Corporation and recognized leader in cardiovascular medical devices, was awarded a $34,000 firm fixed-price purchase order by Veterans Integrated Service Network 23 (VISN 23) on December 12, 2025. The contract, classified as a transcatheter aortic valve replacement (TAVR) procurement, has an ultimate completion date of December 15, 2025 and will be performed in Minneapolis, Minnesota. This award represents a non-competitive,...
- Edwards Lifesciences LLC, a subsidiary of Edwards Lifesciences Corporation and a leader in cardiovascular medical devices, was awarded a $34,000 firm fixed-price purchase order by Veterans Integrated Service Network (VISN) 23 on December 12, 2025, with an ultimate completion date of December 15, 2025. The contract, designated as a TAVR (Transcatheter Aortic Valve Replacement) procurement, will be performed in Minneapolis, Minnesota. This award represents no set-aside designation and reflects the...
- Edwards Lifesciences LLC, a leading developer of advanced cardiovascular medical devices, was awarded a firm fixed-price purchase order valued at $34,000 by Veterans Integrated Service Network 23 (VISN 23) on November 21, 2025, with an ultimate completion date of November 24, 2025. This contract, which received no set-aside designation, is classified as a Purchase Order under the contract type structure. The award supports the VA's mission to provide specialized medical equipment for veteran...
Edwards Lifesciences LLC, a subsidiary of Edwards Lifesciences Corporation and a leader in cardiovascular medical devices, has been awarded a $34,000 firm fixed-price purchase order by Veterans Integrated Service Network (VISN) 23 for prosthetic TAVR (transcatheter aortic valve replacement) kits in the 26mm size. The contract, awarded on October 3, 2025, with an ultimate completion date of October 6, 2025, will be performed in Minneapolis, Minnesota. This procurement does not utilize a set-aside designation and represents a direct supply arrangement for specialized cardiac devices to support veteran healthcare services. Edwards Lifesciences LLC maintains a significant partnership with the Department of Veterans Affairs, serving as the sole manufacturer and prime contractor for advanced transcatheter heart valve technologies across multiple VISNs. This award is consistent with the company's primary federal contracting activity, wherein it supplies highly specialized cardiovascular medical equipment to VA facilities on a firm fixed-price basis. The TAVR kit procurement supports the VA's mission to provide advanced surgical interventions for veterans requiring structural heart disease treatment, with Edwards Lifesciences LLC's specialized expertise enabling access to cutting-edge medical technologies within the federal healthcare system.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $34.0k | 10/3/25 |